Rimonabant 2007Rimonabant 2007News and reports about Rimonabant, know about rimonabant acomplia in 2007 Articles
Rimonabant Trials, Clinical Studies
2007-09-15 22:50:00 The promising preclinical findings with Acomplia (rimonabant) have been confirmed in a series of clinical studies, including pivotal phase III trials involving over 6,000 obese subjects that were carried out in both the US and Europe. Two-year data from the phase III multicentre Rimonabant In Obesity (RIO) trials, which compared rimonabant at doses of 5mg and ... More About: Studies , Trials , Dies , Mona
Rimonabant Clinical Trials| THERAPEUTIC APPROACHES TO TREATMENT OF OBESITY
2007-09-15 22:49:00 Not surprisingly, the growing prevalence of obesity has stimulated the search for drugs to treat this condition. Various therapeutic strategies have been explored, including: Serotonin and noradrenaline reuptake inhibitors (anorectic agents) Lipase inhibitors ß 3-adrenoreceptor agonists Leptin agonists Melanocortin-3 agonists Sanofi-Aventis’ approach is completely different to the above. It developed from the knowledge that cannabis smokers often experience extreme hunger pangs, ... More About: Obesity , Treatment , Clinical Trials , Trials , Rimonabant
Rimonabant : Obesity Predisoposes To Serious Iillness
2007-09-15 22:47:00 Obesity is now the most common nutritional disorder in western industrialised countries. Defined as a body mass index of greater than 30, it arises from the accumulation of excess fat in the body from over consumption of fatty foods. Prevalence of obesity in the US and Europe has reached epidemic levels. Data from the World Health ... More About: Obesity , Rimonabant , Pose , Diso , Mona 1, 2, 3 |
 |
|
 |
